Abstracts - faqs.org

Abstracts

Business

Search abstracts:
Abstracts » Business

Glaxo Wellcome set to pass the acid test

Article Abstract:

Glaxo Wellcome should benefit from a settlement in a court case involving Zantac in the US. The acquisition of Wellcome by Glaxo brings clear benefits such as an expansion of Glaxo's sales base, and cost reductions which should help boost earnings. A boost has been given to the drugs pipeline from projects such as LTC, an Aids treatment. Approval for 3TC in the US should help boost Retrovir sales, since a combination of drugs appears to be more effective. Debt was increased by the takeover, but the debt level should fall.

Publisher: FT Business
Publication Name: Investors Chronicle
Subject: Business
ISSN: 0261-3115
Year: 1995
Glaxo Wellcome PLC

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Oxford Molecular: byte-sized doses

Article Abstract:

Oxford Molecular supplies pharmaceutical concerns with software for developing new drugs. The company aims to develop a standard product for the industry. Pharmaceutical companies face increased costs and are seeking ways of developing drugs more rapidly and more cheaply. The company carries out research consultancy work and supplies drug design ideas to large pharmaceutical concerns, in addition to writing software which it installs and maintains.

Publisher: FT Business
Publication Name: Investors Chronicle
Subject: Business
ISSN: 0261-3115
Year: 1996
Computer software industry, Software industry, Oxford Molecular Group PLC

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Biofocus

Article Abstract:

The performance of Biofocus is examined in detail. The company operates in a market that is growing, and its management is experienced, though stock liquidity is poor.

Publisher: FT Business
Publication Name: Investors Chronicle
Subject: Business
ISSN: 0261-3115
Year: 2001
BioFocus

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Subjects list: Management, Pharmaceutical industry, Drugs
Similar abstracts:
  • Abstracts: Bioglan Pharma. Oxford Molecular
  • Abstracts: Gloves are off in the mega-bids battles. SG Warburg: backing out of Eurobonds. Singer and Friedlander
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.